Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Breast Neoplasms 12Neoplasms 8Multiple Myeloma 8Melanoma 6Hematologic Neoplasms 6Prostatic Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Neoplasm Metastasis 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Thyroid Neoplasms 4Sarcoma 4Lung Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Head and Neck Neoplasms 4Endometrial Neoplasms 4Adenocarcinoma 4Thyroid Cancer, Papillary 3Stomach Neoplasms 3Salivary Gland Neoplasms 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neurofibromatosis 1 3Neurofibroma, Plexiform 3Neuroendocrine Tumors 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3

Interventions

pralsetinib 1ipatasertib 1inavolisib 1entrectinib 1atezolizumab 1alectinib 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Solid Tumors × 90 days × Clear all
NCT04589845 2026-05-08

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Hoffmann-La Roche

Phase 2 Active not recruiting
920 enrolled 1 FDA
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡